Mergers and acquisitions

The acquisition allows cliexa to meet GI customers with an end-to-end automated scheduling, reporting and communications platform.

The digital MSK company is looking to bundle the non-invasive, non-addictive pain reduction device alongside the rest of its employer-focused offerings.

Investment firm Kuwait Life Sciences Company's Dr. Mussaad M. Al-Razouki gives a breakdown of recently filed or finalized digital health SPACs, as well as a list of unicorns ripe for a potential merger.

Hillrom says that lower-than-expected reimbursement rates proposed in late January void the deal. But the cardiac-monitoring device maker asserts they were accounted for during negotiations.

Numan plans to continue its expansion organically and through further M&A activity. 

MindMed plans to use HealthMode's machine learning capabilities into its new digital medicine division. 

Volpara is purchasing all outstanding equity of CRA for $18 million and will pay an additional $4 million if certain strategic targets are met within 18 months.   

The company currently sells connected wearables and smart monitors to consumers, but said that it will be seeking FDA authorization for new products with broader indications and telehealth capabilities down the line.

The M&A is expected to help Flow expand to treat new mental health conditions that are commonly comorbid with depression. 

Saykara's founder and team will be augmenting Nuance's R&D division.